Canopy Growth Corporation ( CGC) - Key Metrics
CGC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.22 | -$0.18 | -$0.05 | -$0.06 |
| 2025Q2 | $0.24 | -$0.01 | -$0.07 | -$0.07 |
| 2025Q1 | $0.38 | -$0.22 | -$0.05 | -$0.06 |
| 2024Q4 | $0.42 | -$1.43 | -$0.21 | -$0.23 |
| 2024Q3 | $0.68 | -$1.11 | -$0.24 | -$0.26 |
CGC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -2.15 |
| 2025Q2 | ? | -84.85 |
| 2025Q1 | ? | -1.90 |
| 2024Q4 | ? | -0.23 |
| 2024Q3 | ? | -0.89 |
CGC
Price: $1.04
52 week price:
Earnings Per Share: -1.35 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 11.1 million
Market Capitalization: 476.0 million